vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $85.1M, roughly 1.5× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.5%, a 21.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -3.9%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $16.3M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -4.8%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
FDMT vs SWBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $124.7M |
| Net Profit | $19.4M | $1.9M |
| Gross Margin | — | 24.3% |
| Operating Margin | 17.3% | 3.3% |
| Net Margin | 22.8% | 1.5% |
| Revenue YoY | 8508900.0% | -3.9% |
| Net Profit YoY | 139.1% | -53.6% |
| EPS (diluted) | $0.43 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $124.7M | ||
| Q3 25 | $90.0K | $85.1M | ||
| Q2 25 | $15.0K | $140.8M | ||
| Q1 25 | $14.0K | $115.9M | ||
| Q4 24 | $1.0K | $129.7M | ||
| Q3 24 | $3.0K | $88.3M | ||
| Q2 24 | $5.0K | $159.1M | ||
| Q1 24 | $28.0K | $137.5M |
| Q4 25 | $19.4M | $1.9M | ||
| Q3 25 | $-56.9M | $-3.4M | ||
| Q2 25 | $-54.7M | $8.6M | ||
| Q1 25 | $-48.0M | $2.1M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-43.8M | $-1.9M | ||
| Q2 24 | $-35.0M | $27.9M | ||
| Q1 24 | $-32.4M | $7.9M |
| Q4 25 | — | 24.3% | ||
| Q3 25 | — | 25.9% | ||
| Q2 25 | — | 28.8% | ||
| Q1 25 | — | 24.1% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | 35.5% | ||
| Q1 24 | — | 28.7% |
| Q4 25 | 17.3% | 3.3% | ||
| Q3 25 | -67983.3% | -3.5% | ||
| Q2 25 | -396373.3% | 9.3% | ||
| Q1 25 | -383007.1% | 4.1% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | -1704400.0% | -1.7% | ||
| Q2 24 | -849120.0% | 17.4% | ||
| Q1 24 | -136200.0% | 8.2% |
| Q4 25 | 22.8% | 1.5% | ||
| Q3 25 | -63195.6% | -4.0% | ||
| Q2 25 | -364386.7% | 6.1% | ||
| Q1 25 | -342657.1% | 1.8% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | -1461433.3% | -2.1% | ||
| Q2 24 | -699060.0% | 17.5% | ||
| Q1 24 | -115717.9% | 5.7% |
| Q4 25 | $0.43 | $0.04 | ||
| Q3 25 | $-1.01 | $-0.08 | ||
| Q2 25 | $-0.98 | $0.19 | ||
| Q1 25 | $-0.86 | $0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.79 | $-0.04 | ||
| Q2 24 | $-0.63 | $0.60 | ||
| Q1 24 | $-0.66 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $22.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $363.2M |
| Total Assets | $566.7M | $548.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $22.4M | ||
| Q3 25 | $305.1M | $18.0M | ||
| Q2 25 | $293.2M | $25.2M | ||
| Q1 25 | $321.4M | $26.7M | ||
| Q4 24 | $424.9M | $39.1M | ||
| Q3 24 | $501.9M | $35.5M | ||
| Q2 24 | $541.9M | $60.8M | ||
| Q1 24 | $525.9M | $47.4M |
| Q4 25 | $505.7M | $363.2M | ||
| Q3 25 | $369.0M | $364.4M | ||
| Q2 25 | $420.9M | $372.5M | ||
| Q1 25 | $469.7M | $366.9M | ||
| Q4 24 | $510.6M | $371.5M | ||
| Q3 24 | $552.9M | $380.0M | ||
| Q2 24 | $588.3M | $399.9M | ||
| Q1 24 | $600.6M | $376.4M |
| Q4 25 | $566.7M | $548.6M | ||
| Q3 25 | $424.0M | $554.6M | ||
| Q2 25 | $473.6M | $559.6M | ||
| Q1 25 | $515.7M | $578.9M | ||
| Q4 24 | $560.4M | $587.4M | ||
| Q3 24 | $604.0M | $571.3M | ||
| Q2 24 | $620.1M | $577.4M | ||
| Q1 24 | $629.9M | $570.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $27.3M |
| Free Cash FlowOCF − Capex | $28.5M | $16.3M |
| FCF MarginFCF / Revenue | 33.5% | 13.1% |
| Capex IntensityCapex / Revenue | 0.1% | 8.8% |
| Cash ConversionOCF / Net Profit | 1.47× | 14.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $21.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $27.3M | ||
| Q3 25 | $-46.5M | $-8.1M | ||
| Q2 25 | $-43.4M | $40.8M | ||
| Q1 25 | $-47.8M | $-9.8M | ||
| Q4 24 | $-134.6M | $-7.4M | ||
| Q3 24 | $-29.4M | $-30.8M | ||
| Q2 24 | $-30.2M | $43.7M | ||
| Q1 24 | $-29.1M | $25.2M |
| Q4 25 | $28.5M | $16.3M | ||
| Q3 25 | $-46.6M | $-12.4M | ||
| Q2 25 | $-43.4M | $33.5M | ||
| Q1 25 | $-48.4M | $-16.1M | ||
| Q4 24 | $-138.4M | $-10.7M | ||
| Q3 24 | $-31.2M | $-35.5M | ||
| Q2 24 | $-30.6M | $38.2M | ||
| Q1 24 | $-29.8M | $7.0M |
| Q4 25 | 33.5% | 13.1% | ||
| Q3 25 | -51765.6% | -14.6% | ||
| Q2 25 | -289620.0% | 23.8% | ||
| Q1 25 | -345635.7% | -13.9% | ||
| Q4 24 | -13837100.0% | -8.3% | ||
| Q3 24 | -1038966.7% | -40.2% | ||
| Q2 24 | -611840.0% | 24.0% | ||
| Q1 24 | -106421.4% | 5.1% |
| Q4 25 | 0.1% | 8.8% | ||
| Q3 25 | 101.1% | 5.0% | ||
| Q2 25 | 440.0% | 5.2% | ||
| Q1 25 | 4507.1% | 5.4% | ||
| Q4 24 | 378600.0% | 2.5% | ||
| Q3 24 | 59266.7% | 5.3% | ||
| Q2 24 | 6980.0% | 3.5% | ||
| Q1 24 | 2535.7% | 13.2% |
| Q4 25 | 1.47× | 14.22× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.73× | ||
| Q1 25 | — | -4.68× | ||
| Q4 24 | — | -1.63× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 3.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
